Istituto Oncologico Veneto
About Istituto Oncologico Veneto
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute, Naples
14
Bristol-Myers Squibb
13
Istituto Oncologico Veneto IRCCS
11
Hoffmann-La Roche
10
Eli Lilly and Company
9
Italian Sarcoma Group
9
European Organisation for Research and Treatment of Cancer - EORTC
8
EMD Serono Research & Development Institute, Inc.
7
Fondazione del Piemonte per l'Oncologia
7
Incyte Corporation
7
Janssen Research & Development, LLC
7
Clinical Trials at Istituto Oncologico Veneto
During the past decade, Istituto Oncologico Veneto conducted 167 clinical trials. In the 10-year time frame, 167 clinical trials started and 39 clinical trials were completed, i.e. on
average, 23.4% percent of trials that started reached the finish line to date. In the past 5 years, 67 clinical trials started and 26 clinical trials were completed. i.e. 38.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The DISTAL-2 Study: Docetaxel Alone or in Combination in Second-line Treatment of Advanced Non Small-Cell Lung Cancer
2005-05-01
2008-05-01
Terminated
84
TORCH: A Study of Tarceva or Chemotherapy for the Treatment of Advanced Non Small Cell Lung Cancer
2006-12-01
2012-06-01
Completed
760
Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC
2003-01-01
2006-07-01
Completed
400
G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly Patients
2000-11-01
2009-02-01
Completed
85
Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer
2007-08-01
2011-11-01
Terminated
80
STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing Study
2007-09-01
2023-12-01
Active, not recruiting
160
CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients
2007-11-01
2012-12-01
Terminated
57
FOLFOX-4 3months Versus 6 Months and Bevacizumab as Adjuvant Therapy for Patients With Stage II/III Colon Cancer
2007-06-01
2014-11-01
Completed
3,756
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Istituto Oncologico Veneto" #1 sponsor was "National Cancer Institute, Naples" with 14 trials, followed by "Bristol-Myers Squibb" with 13 trials
sponsored, "Istituto Oncologico Veneto IRCCS" with 11 trials sponsored, "Hoffmann-La Roche" with 10 trials sponsored and "Eli Lilly and Company"
with 10 trials sponsored. Other sponsors include 184 different institutions and
companies that sponsored additional 88 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Istituto Oncologico Veneto"
#1 collaborator was "AstraZeneca" with 8 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 8 trials as a collaborator, "Merck Sharp & Dohme LLC" with 8 trials as a collaborator, "Hoffmann-La Roche" with 6 trials as a collaborator and "PharmaMar" with 6 trials as a collaborator. Other collaborators include 116 different institutions and companies that were
collaborators in the rest 98 trials.
Clinical Trials Conditions at Istituto Oncologico Veneto
According to Clinical.Site data, the most researched conditions in "Istituto Oncologico Veneto" are
"Metastatic Colorectal Cancer" (13 trials), "Breast Cancer" (12 trials), "Melanoma" (12 trials), "Ovarian Cancer" (7 trials) and "Metastatic Breast Cancer" (5 trials). Many other conditions were trialed in "Istituto Oncologico Veneto" in a lesser frequency.
Clinical Trials Intervention Types at Istituto Oncologico Veneto
Most popular intervention types in "Istituto Oncologico Veneto" are "Drug" (205 trials), "Other" (20 trials), "Biological" (18 trials), "Procedure" (9 trials) and "Radiation" (7 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (24 trials), "Gemcitabine" (17 trials), "Nivolumab" (15 trials), "Atezolizumab" (13 trials) and "Capecitabine" (12 trials). Other intervention names were less common.
Clinical Trials Genders at Istituto Oncologico Veneto
The vast majority of trials in "Istituto Oncologico Veneto" are
214 trials for "All" genders, 28 trials for "Female" genders and 4 trials for "Male" genders.
Clinical Trials Status at Istituto Oncologico Veneto
Currently, there are NaN active trials in "Istituto Oncologico Veneto".
1 are not yet recruiting,
60 are recruiting,
67 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 63 completed trials in Istituto Oncologico Veneto,
undefined suspended trials,
and 22 terminated clinical trials to date.
Out of the total trials that were conducted in Istituto Oncologico Veneto, 16 "Phase 1"
clinical trials were conducted, 95 "Phase 2" clinical
trials and 103 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 5 trials, and there were
also 8 trials that are defined as “Not Applicable".
Departments of Istituto Oncologico Veneto
Istituto Oncologico Veneto has several departments that took part in Clinical trials: "IRCCS Istituto Oncologico Veneto (IOV); Oncologia Medica Prima" - 15 trials, "IOV - Istituto Oncologico Veneto - IRCCS; Oncologia Medica II" - 41 trials, "U.O.C. Oncoematologia - Istituto Oncologico Veneto Irccs, Presidio Ospedaliero S. Giacomo Apostolo" - 3 trials, "Istituto Oncologico Veneto IOV - IRCCS Unità Operativa Complessa Oncologia Medica 1" - 2 trials
Departments List
Name
City
Trials
Castelfranco Veneto
3